Health Technology · Medical Specialties · NSE: GKB · data 2026-10-09

Gkb Ophthalmics Limited

Health check: Strong (6.9/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹60.28

Market cap

₹30 cr

P/E

9.4

P/B

—

ROE

2.3%

ROCE

8.7%

Debt / equity

0.22

Dividend yield

0.00%

1-year return

-28.2%

52-week high

₹76.02

52-week low

₹58.25

Operating margin

4.7%

Growth

Revenue (last 12 months)	₹150 cr
Net profit (last 12 months)	₹3 cr
Sales growth, 3 years (yearly)	25.5%
Profit growth, 3 years (yearly)	—

Similar companies

Nureca Ltd. (NURECA) · Yash Optics and Lens Limited (YASHOPTICS) · Avience Biomedicals Limited (AVIENCE) · Mohini Health & Hygiene Ltd. (MHHL) · Galaxy Medicare Limited (GML)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open GKB in NSE Scanner →